Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin. (Q51335341)
Jump to navigation
Jump to search
scientific article published on 29 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin. |
scientific article published on 29 June 2012 |
Statements
1 reference
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin. (English)
1 reference
L Johansson
1 reference
Ö Ljunggren
1 reference
J Bolinder
1 reference
J Wilding
1 reference
A M Langkilde
1 reference
C D Sjöström
1 reference
J Sugg
1 reference
S Parikh
1 reference
29 June 2012
1 reference
14
1 reference
990-999
1 reference
11
1 reference
Identifiers
1 reference